Article ID Journal Published Year Pages File Type
874669 Journal of Biomechanics 2007 11 Pages PDF
Abstract

Myocardial fractional flow reserve (FFRmyo) and coronary flow reserve (CFR), measured with guidewire, and quantitative angiography (QA) are widely used in combination to distinguish ischemic from non-ischemic coronary stenoses. Recent studies have shown that simultaneous measurements of FFRmyo and CFR are recommended to dissociate conduit epicardial coronary stenoses from distal resistance microvascular disease. In this study, a more comprehensive diagnostic parameter, named as lesion flow coefficient, c˜, is proposed. The coefficient, c˜, which accounts for mean pressure drop, Δp˜, mean coronary flow, Q˜, and percentage area stenosis, can be used to assess the hemodynamic severity of a coronary artery stenoses. Importantly, the contribution of viscous loss and loss due to momentum change for several lesion sizes can be distinguished using c˜.FFRmyo, CFR and c˜ were calculated for pre-angioplasty, intermediate and post-angioplasty epicardial lesions, without microvascular disease. While hyperemic c˜ decreased from 0.65 for pre-angioplasty to 0.48 for post-angioplasty lesion with guidewire of size 0.35 mm, FFRmyo increased from 0.52 to 0.87, and CFR increased from 1.72 to 3.45, respectively. Thus, reduced loss produced by momentum change   due to lower percentage area stenosis decreased c˜. For post-angioplasty lesion, c˜ decreased from 0.55 to 0.48 with the insertion of guidewire. Hence, increased viscous   loss due to the presence of guidewire decreased c˜ compared with a lesion without guidewire. Further, c˜ showed a linear relationship with FFRmyo, CFR and percentage area stenosis for pre-angioplasty, intermediate and post-angioplasty lesion. These baseline values of c˜ were developed from fluid dynamics fundamentals for focal lesions, and provided a single hemodynamic endpoint to evaluate coronary stenosis severity.

Related Topics
Physical Sciences and Engineering Engineering Biomedical Engineering
Authors
, , , , , ,